Galapagos NV (GLPG) - Total assets

#4540

Rank

£1.63 B

Marketcap

🇧🇪 Belgium

Country

£24.76

Share price

-0.73%

Change (1 day)

32.31%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year	Total assets	Change
2024-12-31	£3.42 B	-9.3%
2023-12-31	£3.78 B	-9.93%
2022-12-31	£4.19 B	-3.66%
2021-12-31	£4.35 B	-15.55%
2020-12-31	£5.15 B	-0.48%
2019-12-31	£5.18 B	299.62%
2018-12-31	£1.29 B	13.61%
2017-12-31	£1.14 B	23.65%
2016-12-31	£0.92 B	182.85%
2015-12-31	£0.32 B	54.53%
2014-12-31	£0.21 B	-12.18%
2013-12-31	£0.24 B	24.92%
2012-12-31	£0.19 B	43.12%
2011-12-31	£0.13 B	-19.48%
2010-12-31	£0.16 B	31.35%
2009-12-31	£0.12 B	12.26%
2008-12-31	£0.11 B	3.69%
2007-12-31	£0.10 B	-3.21%
2006-12-31	£0.11 B	101.56%
2005-12-31	£56.02 M	407.88%
2004-12-31	£11.03 M

Total Assets for similar companies or competitors

Company	Total assets	differencediff.	Country
Johnson & Johnson JNJ	£140.89 B	4,578.26%	🇺🇸 USA
Abbott Laboratories ABT	£61.51 B	1,942.47%	🇺🇸 USA
AbbVie ABBV	£97.84 B	3,148.75%	🇺🇸 USA
Sanofi SNY	£111.30 B	3,595.81%	🇫🇷 France
Merck MRK	£94.66 B	3,043.15%	🇺🇸 USA
AstraZeneca AZN	£83.63 B	2,677.03%	🇬🇧 UK
GSK plc GSK	£60.25 B	1,900.72%	🇬🇧 UK
Fortress Biotech FBIO	£0.13 B	-95.60%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	£29.12 B	867.02%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions